Tue, March 5, 2024

Oren Livnat Maintained (AVDL) at Strong Buy with Increased Target to $25 on, Mar 5th, 2024

Oren Livnat of HC Wainwright & Co., Maintained "Avadel Pharmaceuticals plc" (AVDL) at Strong Buy with Increased Target from $21 to $25 on, Mar 5th, 2024.

Oren has made no other calls on AVDL in the last 4 months.



There is 1 other peer that has a rating on AVDL. Out of the 1 peers that are also analyzing AVDL, 0 agree with Oren's Rating of Hold.



This is the rating of the analyst that currently disagrees with Oren


  • Ashwani Verma of "UBS" Initiated at Strong Buy and Held Target at $21 on, Tuesday, February 6th, 2024